We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBO: DRUG FIRMS COULD BLOCK PRICE CUTS UNDER IMPORTATION
CBO: DRUG FIRMS COULD BLOCK PRICE CUTS UNDER IMPORTATION
May 7, 2004
U.S. drugmakers — especially brand companies — would be able to use several options available to them to minimize the effects of changes in prescription drug importation policy on U.S. pharmaceutical prices, including gaining FDA and foreign-government cooperation in limiting the trade practice, according to a report from the Congressional Budget Office (CBO).